<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIMS: Patients with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> often present with abnormal gut motility away from the inflammatory site </plain></SENT>
<SENT sid="1" pm="."><plain>We studied remote motility disturbances and their pathophysiology in a rat model of <z:hpo ids='HP_0002583'>colitis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: <z:hpo ids='HP_0002583'>Colitis</z:hpo> was induced 72 h prior to experiments using <z:chebi fb="0" ids="48110">trinitrobenzene</z:chebi> <z:chebi fb="100" ids="16189">sulphate</z:chebi> (<z:chebi fb="0" ids="53063,53506">TNBS</z:chebi>) instillation </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> was verified using histology and myeloperoxidase (MPO) measurements </plain></SENT>
<SENT sid="4" pm="."><plain>To assess gut motility, we determined gastric emptying, distal front and geometric centre (GC) of intestinal transit 30 min after intragastric administration of a semiliquid Evans blue solution </plain></SENT>
<SENT sid="5" pm="."><plain>The effects of hexamethonium (20 mg/kg), <z:chebi fb="8" ids="3374">capsaicin</z:chebi> (125 mg/kg) and pelvic nerve section on <z:hpo ids='HP_0002583'>colitis</z:hpo> induced motility changes were evaluated </plain></SENT>
<SENT sid="6" pm="."><plain>c-Fos expression was studied in the pelvic nerve dorsal root ganglion (DRG) S1 </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:hpo ids='HP_0002583'>Colitis</z:hpo> reduced gastric emptying from 38.4 (3.6)% in controls to 22.7 (4.4)% in <z:chebi fb="0" ids="53063,53506">TNBS</z:chebi> treated rats in the absence of local gastric <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0002583'>Colitis</z:hpo> had no effect on the distal front or on the geometric centre of small intestinal transit </plain></SENT>
<SENT sid="9" pm="."><plain>Hexamethonium reduced gastric emptying in controls to 26.3 (4.1)% but restored it to 35.8 (4.4)% in <z:chebi fb="0" ids="53063,53506">TNBS</z:chebi> treated rats </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="8" ids="3374">Capsaicin</z:chebi> significantly impaired gastric emptying in controls from 33.1 (5.2)% to 9.5 (3.3)% while this effect was less pronounced in <z:chebi fb="0" ids="53063,53506">TNBS</z:chebi> treated rats (from 19.2 (2.3)% to 11.5 (3.8)%; NS) </plain></SENT>
<SENT sid="11" pm="."><plain>In <z:chebi fb="0" ids="53063,53506">TNBS</z:chebi> treated rats, pelvic nerve section completely restored gastric emptying from 19.8 (5.3)% to 52.5 (6.3)% without any effect on gastric emptying in control rats </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="0" ids="53063,53506">TNBS</z:chebi> <z:hpo ids='HP_0002583'>colitis</z:hpo> induced de novo c-Fos expression in the DRG S1 </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Experimental <z:hpo ids='HP_0002583'>colitis</z:hpo> in rats delays gastric emptying via a neuronal pathway involving pelvic afferent nerve <z:hpo ids='HP_0000752'>hyperactivity</z:hpo> </plain></SENT>
</text></document>